Rock Springs Capital Management LP Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$2.2B
Holdings
147
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (147 positions)
| Stock | Value |
|---|---|
—MEDICINES CO | $5.3M |
ANABANAPTYSBIO INC | $5.2M |
—NABRIVA THERAPEUTICS PLC | $5.1M |
—BLUEBIRD BIO INC | $4.8M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $4.7M |
—MYOVANT SCIENCES LTD | $4.6M |
—ADURO BIOTECH INC | $4.4M |
EX9EXELIXIS INC | $4.2M |
MGNXMACROGENICS INC | $4.2M |
—EGALET CORP | $4.1M |
—MEDICINES CO | $3.8M |
—ALLERGAN PLC | $3.8M |
CBAYUSDCYMABAY THERAPEUTICS INC | $3.6M |
DVAXDYNAVAX TECHNOLOGIES CORP | $3.5M |
MCRB1EURSERES THERAPEUTICS INC | $3.5M |
—ZOGENIX INC | $3.5M |
BMYBRISTOL MYERS SQUIBB CO | $3.2M |
IRWDIRONWOOD PHARMACEUTICALS INC | $3.2M |
CGENCOMPUGEN LTD | $3.1M |
—DBV TECHNOLOGIES S A | $3.1M |
ITCIEURINTRA CELLULAR THERAPIES INC | $3.0M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $2.6M |
—CARDIOME PHARMA CORP | $2.6M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $2.5M |
ZBHZIMMER BIOMET HLDGS INC | $2.5M |
—CIDARA THERAPEUTICS INC | $2.4M |
—ATYR PHARMA INC | $2.4M |
BCRXBIOCRYST PHARMACEUTICALS | $2.4M |
SG7SAGE THERAPEUTICS INC | $2.0M |
—THERAVANCE BIOPHARMA INC | $1.8M |
SCYXEURSCYNEXIS INC | $1.8M |
NVLSEURALPINE IMMUNE SCIENCES INC | $1.7M |
—MYOKARDIA INC | $1.7M |
—RADIUS HEALTH INC | $1.5M |
—DIMENSION THERAPEUTICS INC | $1.4M |
—CHIASMA INC | $1.3M |
—WRIGHT MED GROUP INC | $1.1M |
—PROTEOSTASIS THERAPEUTICS IN | $945K |
NVAXNOVAVAX INC | $935K |
—NEWLINK GENETICS CORP | $738K |
KALAKALA PHARMACEUTICALS INC | $571K |
—TANDEM DIABETES CARE INC | $411K |
—EGALET CORP | $384K |
INFIQINFINITY PHARMACEUTICALS INC | $359K |
—OREXIGEN THERAPEUTICS INC | $350K |
DAREDARE BIOSCIENCE INC | $195K |
ANTHANTHERA PHARMACEUTICALS INC | $155K |
PreviousPage 2 of 2